A pivotal study of BI-1206 for the treatment of Non-Hodgkin's Lymphoma
Latest Information Update: 01 Mar 2021
At a glance
- Drugs BI 1206 (Primary)
- Indications Non-Hodgkin's lymphoma
- Focus Registrational; Therapeutic Use
- 01 Mar 2021 New trial record